250,000 new jersey residents already received the johnson and johnson vaccine, now what?

250,000 New Jersey residents already received the Johnson and Johnson vaccine, now what?

The FDA and CDC issued a joint statement in support of pausing the distribution and administering the Johnson and Johnson COVID-19 vaccines, but not until after 244,000 New Jersey residents received it.

New Jersey Governor Phil Murphy said there’s no reason to panic or worry about the news.

Related: Trump slams Biden over halt of Johnson and Johnson Vaccine

“Our decision to temporarily pause the administration of Johnson & Johnson’s vaccine [is] upon the recommendation of the Centers for Disease Control and Prevention, and the Food and Drug Administration, pending further investigation into six reported incidences of severe blood clots following vaccinations,” Murphy said. “Now, for sure, these six cases each appear to be extremely rare and serious as there had been nearly seven million doses of the Johnson & Johnson vaccine administered nationwide.”

Of the nearly 7 million doses administered so far in the United States, a small number of  cases of a rare and severe type of blood clot have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine, the CDC said.

Related: CDC, FDA Want to Halt J&J Vaccine after blood clot issues arise in patients

“The use of this vaccine is ‘paused’ for now. This is because the safety systems that make sure vaccines are safe received a small number of reports of a rare and severe type of blood clot happening in people who got this vaccine,” the CDC said in a statement. “We do not know enough yet to say if the vaccine is related to or caused this health issue. To be extra careful, CDC and FDA recommend that the vaccine not be given until we learn more.”

The CDC said the following side effects were found in the J&J vaccine:

  • severe headache,
  • backache,
  • new neurologic symptoms,
  • severe abdominal pain,
  • shortness of breath,
  • leg swelling,
  • tiny red spots on the skin (petechiae), or
  • new or easy bruising

“In New Jersey, where we had administered just over 244,000 doses of the Johnson & Johnson vaccine prior to hitting pause, no similar adverse effects have been reported,” the Governor said. “Even with this pause, our overall goal of vaccinating 4.7 million adult New Jerseyans by the end of June remains not only in place, but entirely achievable. As of today, doses of Johnson & Johnson have accounted for only about 4%, Judy, of the more than 5.6 million total vaccine doses we have administered. I want to repeat that no one who has received this vaccine should panic or worry.”

This pause also has no effect on Monday’s opening vaccine eligibility to all New Jerseyans age 16 and over.

“We will keep pushing forward with the tools available to us,” Murphy added.

Phil Stilton

Phil Stilton is the Editor and Publisher of Shore News Network, an independent digital newsroom providing original reporting on New Jersey, national news, government, public policy, public safety, courts, and community affairs.

As founder of the publication, Stilton leads editorial strategy, investigative reporting, and daily newsroom operations while overseeing coverage that reaches millions of readers annually.

With extensive experience covering municipal government, county government, state legislatures, elections, law enforcement, emergency management, and public records, Stilton specializes in translating complex government actions into clear, factual reporting. His work frequently relies on primary source documents, including court filings, legislation, public meeting records, election finance disclosures, government databases, police reports, and Freedom of Information and Open Public Records Act (OPRA) requests. He has reported extensively on local government accountability, taxpayer spending, campaign finance, public corruption investigations, infrastructure, public safety, and the policies affecting New Jersey residents.

Under Stilton's editorial leadership, Shore News Network has grown into one of New Jersey's largest independent digital news organizations, publishing thousands of original news articles each year while providing breaking news coverage, investigative reporting, and analysis across state and local government. The publication's reporting is routinely sourced from official government agencies, public officials, court records, and firsthand documentation, with a commitment to transparency, attribution, corrections when warranted, and clearly distinguishing factual reporting from opinion.

Stilton's journalism follows established newsroom standards emphasizing accuracy, verification, fairness, and accountability. Every effort is made to verify information through official records and multiple reliable sources before publication. His reporting is intended to provide readers with timely, well-documented information that helps them understand the issues affecting their communities, while maintaining editorial independence from political parties, government agencies, advocacy organizations, and commercial interests.

Readers can submit story tips, corrections, public records, or media inquiries through the official Shore News Network website or its verified social media channels. Shore News Network welcomes corrections and updates when new information becomes available as part of its ongoing commitment to accurate and transparent journalism.